We are confident that our findings are of utmost relevance for the clinical care of HFE‐HH patients and will aid in targeting the mechanisms of bone loss during iron‐overload pathology rather than focusing on the diversion of HFE/Hfe mutations and the iron overload itself. This evidence concerns the gene HFE and Tangier disease.